Nephritis- urinary system disease
Transcript of Nephritis- urinary system disease
-
7/30/2019 Nephritis- urinary system disease
1/18
NEPHRITISTubulointerstitial
Nephritis (TIN)
Ms. Harpreet Kaur
Lecturer
-
7/30/2019 Nephritis- urinary system disease
2/18
DEFINITION
Nephritis suggests a noninfectious inflammatory
process that involves the nephron .
Term nephritis is also applied to a group of unrelated
inflammatory disorders known collectivelyas tubulointerstitial nephritis (TIN) . TIN initially
affects mainly the interstitium and renal tubules
Nephritis is term used to clinically denote a child
with hypertension, decreased renal function,
hematuria, and edema.
-
7/30/2019 Nephritis- urinary system disease
3/18
ETIOLOGY
Antigen-antibody complexes trapped in the renal
parenchyma : process of inflammation and cell
proliferation, in which endothelial or epithelial cells
are stimulated to proliferate in varying degrees, isinitiated, which damages normal renal tissue
An infection, a drug, a metabolic abnormality
-
7/30/2019 Nephritis- urinary system disease
4/18
EPIDEMIOLOGY
TIN is very rare in children younger than age 5
years. Acute TIN can potentially occur in
people of any age. Chronic TIN tends to occur
late in childhood or adolescence
-
7/30/2019 Nephritis- urinary system disease
5/18
CLINICAL MANIFESTATIONS
Allergic manifestations, most have fever
Nonspecific symptoms, such as malaise, fever,
anorexia, or weakness, may be present
Facial swelling and perioral, or pedal edema orascites
Symptoms of pulmonary edema or congestive heart
failure (eg, dyspnea with exertion, orthopnea,shortness of breath) may be present
-
7/30/2019 Nephritis- urinary system disease
6/18
CLINICAL MANIFESTATIONS
Gross hematuria (eg, dark, rust colored, coke
colored, tea colored) may be present.
With severe hypertension, identify nosebleed,
headache, or encephalopathy.
-
7/30/2019 Nephritis- urinary system disease
7/18
DIAGNOSTIC EVALUATION
PHYSICAL EXAMINATION
Elevated blood pressure is an important physical
finding
Look for edema
The child may have a pale appearance
Tachypnea, dyspnea, hepatic congestion, and gallop
rhythm suggest fluid overload with congestive heartfailure
-
7/30/2019 Nephritis- urinary system disease
8/18
DIAGNOSTIC EVALUATION CONTD..
With tubulointerstitial nephritis (TIN), physicalfindings include maculopapular rash, joint pain(with flexion and extension), and fever
LABORATORY STUDIES
Electrolyte, creatinine, and blood urea nitrogen(BUN) levels
Complete blood count (CBC)
Urinalysis
Urine culture
-
7/30/2019 Nephritis- urinary system disease
9/18
DIAGNOSTIC EVALUATION CONTD..
Lupus serologies Measurement of complement components (ie, C3,
C4)
Antistreptolysin-O (ASO) titer
Anti-DNAase B
Perinuclear antineutrophil cytoplasmic antibody (P-
ANCA) measurement
Cellular antineutrophil cytoplasmic antibody (C-
ANCA) assessment
-
7/30/2019 Nephritis- urinary system disease
10/18
DIAGANOSTIC EVALUATION CONTD..
Serum IgA measurement
Laboratory findings in tubulointerstitial
nephritis (TIN) include hematuria,
eosinophilia, sterile pyuria, low-grade
proteinuria, eosinophiluria, and urinary white
blood cell casts
-
7/30/2019 Nephritis- urinary system disease
11/18
DIAGANOSTIC EVALUATION CONTD..
IMAGING STUDIES
Renal ultrasonography is usually performed to
exclude other causes of hypertension and hematuria,
such as renal artery stenosis (ie, small, abnormalkidney on one side)
No imaging tests are sensitive or specific for TIN.
Renal ultrasonography may show large kidney
-
7/30/2019 Nephritis- urinary system disease
12/18
TREATMENT
INPATIENT CARE
Inpatient care is usually necessary only to manage
severe hypertension or complications of acute or
chronic renal failure (eg, dialysis access, uremicsyndrome, congestive heart failure, electrolyte
abnormalities such as hyperkalemia and pericardial
effusion)
-
7/30/2019 Nephritis- urinary system disease
13/18
TREATMENT
OUTPATIENT CARE
Involve the use of antihypertensive, diuretics,
and diet modification
Outpatient therapy may involve dialysis in a
child who develops end-stage renal disease
-
7/30/2019 Nephritis- urinary system disease
14/18
TREATMENT
DIET AND ACTIVITY
Fluid restriction may prevent fluid overload
Fluid restriction of 300 mL/m2/d plus losses may allow
In patients with hypertension, sodium restriction to therecommended daily allowance (RDA) of 2-4 mEq/kg/d may aid
in management In children with renal failure, potassium restriction is justified
to prevent hyperkalemia
A short-term high-carbohydrate diet may prevent catabolism
of body protein as an energy source Calcium supplementation is useful to maintain normal serum
calcium
-
7/30/2019 Nephritis- urinary system disease
15/18
-
7/30/2019 Nephritis- urinary system disease
16/18
MEDICAL MANAGEMENT
ACE Inhibitors
Captopril, a competitive ACE inhibitor, prevents theconversion of angiotensin I to angiotensin II, a potentvasoconstrictor, increasing levels of plasma renin andreducing aldosterone secretion
A competitive ACE inhibitor, enalapril reducesangiotensin II levels, decreasing aldosterone
secretion. The drug lowers systemic arterial bloodpressure, reducing injury caused by elevated bloodpressure
-
7/30/2019 Nephritis- urinary system disease
17/18
MEDICAL MANAGEMENT
Angiotensin II Receptor Antagonists
Losartan is a prototype ARB. It is specific for the type 1, as
opposed to type 2, angiotensin receptor. It may induce more
complete inhibition of the renin-angiotensin system than do
ACE inhibitors
Valsartan is a prodrug that directly antagonizes angiotensin II
receptors. It displaces angiotensin II from the AT1 receptor
and may lower blood pressure by antagonizing AT1-induced
vasoconstriction, aldosterone release, catecholamine release,arginine vasopressin release, water intake, and hypertrophic
responses
-
7/30/2019 Nephritis- urinary system disease
18/18
MEDICAL MANAGEMENT
Calcium Channel Blockers
Calcium channel blockers, nifedipine causes peripheral arterial
vasodilation by inhibiting calcium influx across vascular
smooth-muscle cell membranes
Beta Adrenergic Blockers
Labetalol blocks alpha-1 beta 1-, and beta 2-adrenergic
receptor sites, decreasing BP
Propranolol has membrane-stabilizing activity and decreases
automaticity of contractions. Propranolol is not suitable for
emergency treatment of hypertension. Do not administer IV
in hypertensive emergencies